Free Trial
NYSE:ALB

Albemarle (ALB) Stock Price, News & Analysis

Albemarle logo
$89.37 -0.88 (-0.97%)
As of 12:24 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Albemarle Stock (NYSE:ALB)

Key Stats

Today's Range
$88.90
$90.90
50-Day Range
$85.23
$111.30
52-Week Range
$71.97
$143.19
Volume
834,256 shs
Average Volume
2.00 million shs
Market Capitalization
$10.50 billion
P/E Ratio
N/A
Dividend Yield
1.81%
Price Target
$115.65
Consensus Rating
Hold

Company Overview

Albemarle Corporation's history dates back to 1887. Today, the company is a leading specialty chemicals producer based in Charlotte, North Carolina. 

Albemarle Corporation manufactures and markets custom-engineered specialty chemicals for various industries. This range of industries spreads across many sectors, including consumer electronics, pharmaceuticals, energy storage, petroleum refining, construction, automotive, lubricants, pharmaceuticals and crop protection. Albemarle Corporation operates through three core segments: lithium, bromine and catalysts.

The lithium segment develops and manufactures a range of lithium compounds. These compounds include lithium carbonate, lithium hydroxide and lithium chloride. Albemarle Corporation also manufactures value-added lithium specialty products and reagents, which include chemicals such as butyllithium and lithium aluminum hydride. 

Customers use Albemarle's products in various applications, including pharmaceuticals, water treatment and paper production. Albemarle Corporation is the largest provider of lithium for electric vehicle batteries and lithium storage products. Albemarle Corporation's other applications include producing various plastic bottles, high-performance greases, thermoplastic elastomers for car tires and thermoplastic elastomers for rubber-soled footwear.  

Albemarle Corporation's bromine segment refines bromine, a naturally occurring element similar to bleach. Albemarle Corporation also manufactures bromine-based fire safety solutions that enhance materials' flame-resistant properties. Albemarle Corporation's bromine segment also manufactures specialty chemicals such as elemental bromine, bromine alkyl, inorganic bromides, brominated powdered activated carbon and other bromine-refined chemicals. Consumers use the products developed in the Albemarle Corporation's bromine segment in various applications — chemical synthesis, petroleum well drilling, well drilling completion fluids, power generation mercury control, industrial water purification, consumable meat processing and other industrial applications. 

The catalysts segment manufactures hydroprocessing, isomerization and alkylation catalysts, fluidized catalytic cracking catalysts, fluidized catalytic cracking additives, organometallics and organometallic curatives. The catalyst products created by Albemarle Corporation are used in petroleum refining applications. The same catalysts are used in producing biofuels, gas-to-liquid refinement and coal liquefaction. Albemarle Corporation also produces fine chemicals (chemical substances prepared to a very high degree of purity) for use in the pharmaceutical and life sciences industries.

Albemarle Corporation builds on its long history by providing innovative and reliable products to a wide range of industries. Albemarle Corporation firmly commits to safety, sustainability and product quality. The company is well-positioned for future growth with production plants in the United States, the Netherlands, Belgium, China, Germany, Austria, the United Kingdom, France, Brazil and Japan. 

Albemarle Corporation was ranked on the Fortune 1000 list in 2020 with a ranking of 916. This ranking strengthened in 2021 and 2022 to 780 and 776, respectively. 

Albemarle Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
76th Percentile Overall Score

ALB MarketRank™: 

Albemarle scored higher than 76% of companies evaluated by MarketBeat, and ranked 80th out of 191 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Albemarle has received a consensus rating of Hold. The company's average rating score is 2.26, and is based on 7 buy ratings, 15 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Albemarle has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Albemarle's stock forecast and price target.
  • Earnings Growth

    Earnings for Albemarle are expected to grow in the coming year, from ($1.49) to $1.75 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Albemarle is -5.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Albemarle is -5.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Albemarle has a PEG Ratio of 3.36. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Albemarle has a P/B Ratio of 1.09. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Albemarle's valuation and earnings.
  • Percentage of Shares Shorted

    11.25% of the outstanding shares of Albemarle have been sold short.
  • Short Interest Ratio / Days to Cover

    Albemarle has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in Albemarle has recently increased by 0.23%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Albemarle pays a meaningful dividend of 1.72%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Albemarle has been increasing its dividend for 30 years.

  • Dividend Sustainability

    Based on EPS estimates, Albemarle will have a dividend payout ratio of 92.57% in the coming year. This indicates that Albemarle may not be able to sustain their current dividend.

  • Read more about Albemarle's dividend.
  • Percentage of Shares Shorted

    11.25% of the outstanding shares of Albemarle have been sold short.
  • Short Interest Ratio / Days to Cover

    Albemarle has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in Albemarle has recently increased by 0.23%, indicating that investor sentiment is decreasing.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Albemarle this week, compared to 5 articles on an average week.
  • Search Interest

    Only 37 people have searched for ALB on MarketBeat in the last 30 days. This is a decrease of -12% compared to the previous 30 days.
  • MarketBeat Follows

    Only 16 people have added Albemarle to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Albemarle insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $255,328.00 in company stock.

  • Percentage Held by Insiders

    Only 0.38% of the stock of Albemarle is held by insiders.

  • Percentage Held by Institutions

    92.87% of the stock of Albemarle is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Albemarle's insider trading history.
Receive ALB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Albemarle and its competitors with MarketBeat's FREE daily newsletter.

ALB Stock News Headlines

Outperform BTC without owning any crypto?
I want to let you in on what may be the hottest crypto discovery of all time… One that has NOTHING to do with creating a crypto wallet or touching ANY risky coin for that matter. Instead, it’s a way that could let regular folks like you and me target 10X the possible results you’d expect from buying Bitcoin … in just a fraction of the time It sounds nuts… trust me I know that… But just as I would hate for you to jump into any risky crypto asset… That’s exactly how I would hate for you to miss out on what could be a safer and better way to benefit from the crypto bull run of 2024. Which is why I’m giving you an opportunity to get all the details of this iconic crypto discovery with you for the first time ever… completely free…
See More Headlines

ALB Stock Analysis - Frequently Asked Questions

Albemarle's stock was trading at $86.08 at the beginning of the year. Since then, ALB stock has increased by 4.0% and is now trading at $89.4910.
View the best growth stocks for 2025 here
.

Albemarle Co. (NYSE:ALB) announced its earnings results on Wednesday, July, 31st. The specialty chemicals company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.53 by $0.49. The firm's revenue was down 39.7% on a year-over-year basis.
Read the conference call transcript
.

Albemarle subsidiaries include MRL’s Wodgina Project, Rockwood Holdings, ACI Cyprus L.L.C., Albemarle Argentina S.R.L., Albemarle Brazil Holdings LTDA., Albemarle Care Fund, Albemarle Catalysts Company B.V., and others.

Top institutional shareholders of Albemarle include Manning & Napier Advisors LLC (0.85%), HB Wealth Management LLC (0.44%), Perpetual Ltd (0.11%) and Janney Montgomery Scott LLC (0.08%). Insiders that own company stock include J Kent Masters, Scott Tozier, Eric Norris, Mark Richard Mummert, Karen G Narwold, John Clarence Barichivich III, Kristin M Coleman and Netha N Johnson.
View institutional ownership trends
.

Shares of ALB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Albemarle investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Chevron (CVX), Netflix (NFLX) and Broadcom (AVGO).

Company Calendar

Last Earnings
7/31/2024
Ex-Dividend for 1/2 Dividend
12/13/2024
Dividend Payable
1/02/2025
Today
1/23/2025
Next Earnings (Estimated)
2/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Industry
Plastics materials & resins
Sub-Industry
Specialty Chemicals
CUSIP
01265310
Employees
9,000
Year Founded
1994

Price Target and Rating

Average Stock Price Target
$115.65
High Stock Price Target
$170.00
Low Stock Price Target
$78.00
Potential Upside/Downside
+29.4%
Consensus Rating
Hold
Rating Score (0-4)
2.26
Research Coverage
23 Analysts

Profitability

Net Income
$1.57 billion
Pretax Margin
-42.47%

Debt

Sales & Book Value

Annual Sales
$9.62 billion
Cash Flow
$24.69 per share
Book Value
$82.36 per share

Miscellaneous

Free Float
117,093,000
Market Cap
$10.50 billion
Optionable
Optionable
Beta
1.58

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NYSE:ALB) was last updated on 1/23/2025 by MarketBeat.com Staff
From Our Partners